REVB Q2 2024 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$7,220

Operating Income

-$3M

Net Income

-$8M

EPS (Diluted)

$-82.09

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$32,095

Balance Sheet

Total Assets

$12M

Total Liabilities

$11M

Stockholders' Equity

$1M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$7,220	-$6,262	-15.3%
Operating Income	-$3M	-$2M	-30.5%
Net Income	-$8M	-$1M	-479.3%